Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
14.4M
-
Number of holders
-
152
-
Total 13F shares, excl. options
-
11M
-
Shares change
-
-59.7K
-
Total reported value, excl. options
-
$538M
-
Value change
-
-$2.61M
-
Put/Call ratio
-
0.74
-
Number of buys
-
66
-
Number of sells
-
-77
-
Price
-
$48.96
Significant Holders of Anika Therapeutics, Inc. - Common Stock, par value $0.01 per share (ANIK) as of Q4 2016
174 filings reported holding ANIK - Anika Therapeutics, Inc. - Common Stock, par value $0.01 per share as of Q4 2016.
Anika Therapeutics, Inc. - Common Stock, par value $0.01 per share (ANIK) has 152 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11M shares
of 14.4M outstanding shares and own 76.25% of the company stock.
Largest 10 shareholders include BlackRock Fund Advisors (1.17M shares), WELLINGTON MANAGEMENT GROUP LLP (1.12M shares), VANGUARD GROUP INC (845K shares), DIMENSIONAL FUND ADVISORS LP (732K shares), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (635K shares), THOMPSON SIEGEL & WALMSLEY LLC (498K shares), BTIM Corp. (385K shares), BlackRock Institutional Trust Company, N.A. (382K shares), AMI ASSET MANAGEMENT CORP (318K shares), and STATE STREET CORP (317K shares).
This table shows the top 152 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.